Medtronic is driving growth through a series of recent product launches and approvals in its key Cardiovascular portfolio, including systems approved in the U.S. and E.U. These launches necessitate investment in marketing automation, sales enablement tools, and supply chain logistics to support global commercialization.
Filing excerpt
The Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access. The system was approved by the U.S. FDA in March 2024 and received CE Mark in late October 2024.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Regions named
sec-10kproductLaunchGet every 10-K signal for Medtronic and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medtronic this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/b25a172c-72e4-4be4-a1e3-80078159903e returns this record as JSON. POST /v1/companies/enrich returns every signal for medtronic.com.
{
"signal_id": "b25a172c-72e4-4be4-a1e3-80078159903e",
"signal_type": "sec-10k",
"signal_subtype": "productLaunch",
"detected_at": "2026-06-23T07:10:36.466+00:00",
"company": {
"name": "Medtronic",
"domain": "medtronic.com"
},
"data": {
"detail": "Medtronic is driving growth through a series of recent product launches and approvals in its key Cardiovascular portfolio, including systems approved in the U.S. and E.U. These launches necessitate investment in marketing automation, sales enablement tools, and supply chain logistics to support global commercialization.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Launched multiple new cardiovascular products, including Evolut FX+ TAVR and Affera Sphere-360 catheter.",
"excerpts": "The Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access. The system was approved by the U.S. FDA in March 2024 and received CE Mark in late October 2024.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/mdt-20260424.htm",
"filing_date": "2026-06-18",
"filing_year": 2026,
"fiscal_year_end": "04/24",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"U.S.",
"E.U."
],
"technologies_mentioned": [
"pulsed field ablation",
"TAVR"
]
}
}
curl https://signals.autobound.ai/v1/signals/b25a172c-72e4-4be4-a1e3-80078159903e \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"medtronic.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.